Financial BO

Goods

Medicines

T-883/MPPHSCL/Pharma/RC/2026 Date-01-04-2026

Madhya Pradesh Public Health Services Corporation Ltd.

MPPHSCL | Bhopal, Madhya Pradesh

Amount: Refer DocsCloses: 24 Apr 2026Closed

Bids

Item Wise

4 Bids29 May 2026

#	Company	Amount	Status
1	₹1.96Admitted-Finance	₹1.96	Admitted-Finance
2	₹2.99Admitted-Finance	₹2.99	Admitted-Finance
3	₹9Admitted-Finance	₹9	Admitted-Finance
4	₹193.91Admitted-Finance	₹193.91	Admitted-Finance

BoQ Line Items

Line Items (13)

Sl No	Description	Qty	Unit	ALPA LABORATORIES LTD.	SYSTOCHEM LABORATORIES LTD	Medipol Pharmaceutical India Pvt Ltd	CIPCO LIMITED
1.00Drugs
1.01	Amisulpride (100 mg), Tablet	5,688	10X10	-	-	-	-
1.02	Anti Thymocyte Globulin (250mg/5ml), Injection	385	5ml Vial	-	-	-	-
1.03	Chloroquine phosphate Tab.(250mg),Tablet	77,197	10X10	-	-	159.18 ₹159.18	-
1.04	Chlorpheniramine Maleate (4mg), Tablet	3,84,038	10X10	-	-	34.73 ₹34.73	9 ₹9
1.05	Disodium Hydrogen Citrate(1.4gm/5ml)(200ml),Syrup	1,40,250	200 ml Bottle	-	-	-	-
1.06	Dobutamine(12.5 mg / ml 20 ml Vial), Injection	26,917	Vial	-	-	-	-
1.07	Glycerine Solution (WHO-GMP Certification exempted for this item)(100 ml ), Bottle	55,847	100 Ml Bottle	-	-	-	-
1.08	Human Insulin Regular/Soluble(40IU/ml (10ml vial)), Injection	77,306	Vial	-	-	-	-
1.09	LetroZole(2.5 mg),Tablet	2,226	10X10	-	-	-	-

Tender Value

Refer Docs

EMD Value

₹2 L

Closing Date

24 Apr 2026, 3:00 pmClosed

Tender Inviting Organisation

Name

Managing Director

Address

MPPHSCL, Bhopal

Work Description

Online Tender for the Rate Contract and Supply of Pharmaceuticals to Various Hospitals of Government of Madhya Pradesh for a Period of 18 months

Tender Information

Tender ID

2026_PHSCL_496449_1

Reference Number

T-883/MPPHSCL/Pharma/RC/2026 Date-01-04-2026

Tender Type

Open Tender

Product Category

Medicines

Period of Work

45 days

Location

MPPHSCL

Source Website

Subscribe to view

Eligibility / Pre-Qualification

Please refer Tender documents.

Documents Required

23 documents required · 23 mandatory

Fee/PreQual/Technical

RequiredEMD Scan Copy (.pdf)

RequiredDocumentary evidence for the constitution of the company (.pdf)

RequiredThe instruments such as power of attorney (.pdf)

RequiredAuthorization letter nominating a responsible person (.pdf)

RequiredAnnual turnover statement for 3 years (.pdf)

RequiredGST registration certificate (Clearly showing GST no). (.pdf)

RequiredChecklist (Annexure XIV) (.pdf)

RequiredGS1 registration certificate (.pdf)

RequiredMandate Form (Annexure-XIII) (.pdf)

RequiredList of items and their quantity quoted (.pdf)

RequiredDeclaration in the format given in Annexure-II (.pdf)

RequiredValid own manufacturing license or valid import license issued by competent authority (.pdf)

RequiredAttested photocopy of import license (.pdf)

RequiredMarket standing cum performance Certificate (.pdf)

Requiredvalid WHO-GMP model certificate or valid USFDA/MHRA certificate (.pdf)

Requiredproduct wise Certificate of COPP/WHO-GMP or valid USFDA/MHRA certificate (.pdf)

RequiredBidder should be produce formulation wise annual production capacity certificate as per annexureVIII (.pdf)

RequiredClarification documents (.pdf)

RequiredThe bidder shall also furnish declaration in the format given in Annexure XVI (.pdf)

RequiredBidder must submit Merged Single PDF of all the above technical documents (.pdf)

RequiredBidder must submit Check list II (Annexure XVIII), in excel format. (.xls)

RequiredOther Documents if any (.pdf)

Finance

RequiredPrice Sheet (.xls)

Fee & Financial Details

Tender Fee Amount

₹6,490

Tender Fee Exemption Allowed

Yes

EMD Fee Amount

₹2 L

EMD Fee Exemption Allowed

Yes

Pre-Bid Meeting

Meeting Place

MPPHSCL, Bhopal

Important Dates

Last Activity

29 May 2026

Published

1 Apr 2026

Bid Opening

27 Apr 2026

Download Starts

1 Apr 2026

Download Ends

24 Apr 2026

Submission Starts

10 Apr 2026

Pre-Bid Meeting

6 Apr 2026

Bill of Quantities

Item WiseBoQ_Ver4.0INR

BoQ1 (13 items)

Sl No	Description	Qty	Unit	Est. Rate	Est. Amount	Item Code
1Drugs
1.01	Amisulpride (100 mg), Tablet	5,688	10X10	-	-	120405
1.02	Anti Thymocyte Globulin (250mg/5ml), Injection	385	5ml Vial	-	-	202109153
1.03	Chloroquine phosphate Tab.(250mg),Tablet	77,197	10X10	-	-	110159
1.04	Chlorpheniramine Maleate (4mg), Tablet	3,84,038	10X10	-	-	110048
1.05	Disodium Hydrogen Citrate(1.4gm/5ml)(200ml),Syrup	1,40,250	200 ml Bottle	-	-	120809
1.06	Dobutamine(12.5 mg / ml 20 ml Vial), Injection	26,917	Vial	-	-	110243
1.07	Glycerine Solution (WHO-GMP Certification exempted for this item)(100 ml ), Bottle	55,847	100 Ml Bottle	-	-	110259
1.08	Human Insulin Regular/Soluble(40IU/ml (10ml vial)), Injection	77,306	Vial	-	-	110300
1.09	LetroZole(2.5 mg),Tablet	2,226	10X10	-	-	120728

Stage Documents

Stage Summary Snapshot

stage.html

html • 0.03 MB

Technical Evaluation

tech_eval.pdf

PDF

Financial Bid Opening

boq_comp_chart.xlsx

xlsx

Documents

Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.

Tender Page Snapshot

details.html

html • 0.04 MB

NIT Documents

Tendernotice_1.pdf

PDF • 0.77 MB

Work Item Documents

TenderDocumentT883.pdf

Tender Documents • 2.08 MB

SupplierFirmBiddingFormChecklistIIAnnexureXVIIIT883.rar

Ready to Participate?

Download all tender documents and submit your bid